Immunotherapy a new weapon against advanced cancer

London, June 2 (IANS) In what could completely alter the course of cancer treatment globally, a combination of immunotherapy — helping the body’s own defences to fight cancer cells — drugs has shown impressive results for terminally-ill melanoma patients in Britain.

According to a Guardian report, half of the terminally-ill patients in the British trial responded to ipilimumab, a drug licensed four years ago, combined with the new drug nivolumab.

The combination of the two drugs shrank the tumours in 58 percent of patients. Scientists from Royal Marsden hospital in London that performed the trials hope that the tumours may finally disappear altogether.

Results from the trial of 945 patients were published in the New England Journal of Medicine.

Immunotherapy is the most exciting development in cancer treatment in years.

According to experts, the results of a trial involving a combination of two new immunotherapy drugs for melanoma (skin cancer) patients are spectacular.

Immunotherapy could offer hope to people with cancers that are otherwise difficult to treat.

Researchers, however, are yet to study the long-term survival rates for immunotherapy.

Melanoma, though a skin cancer, can spread to the lungs, liver, bone, lymph nodes and brain.

The research work is being presented at the annual conference of the American Society of Clinical Oncology in Chicago this week.

Leave a Reply

Please enter your comment!

The opinions, views, and thoughts expressed by the readers and those providing comments are theirs alone and do not reflect the opinions of www.mangalorean.com or any employee thereof. www.mangalorean.com is not responsible for the accuracy of any of the information supplied by the readers. Responsibility for the content of comments belongs to the commenter alone.  

We request the readers to refrain from posting defamatory, inflammatory comments and not indulge in personal attacks. However, it is obligatory on the part of www.mangalorean.com to provide the IP address and other details of senders of such comments to the concerned authorities upon their request.

Hence we request all our readers to help us to delete comments that do not follow these guidelines by informing us at  info@mangalorean.com. Lets work together to keep the comments clean and worthful, thereby make a difference in the community.

Please enter your name here